Latest Commercialization News

Provaris Energy has achieved a major breakthrough with a term sheet for green hydrogen supply to Uniper, marking Europe's first large-scale regional hydrogen marine transport project. Concurrently, the company is advancing innovative CO2 tank designs in partnership with Yinson, positioning itself at the forefront of energy transition infrastructure.

Pure Resources Limited has made significant strides in its Reedy Creek Garnet Project, expanding the resource and delivering promising metallurgical test results that highlight the project's commercial potential.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.

Talga Group has achieved critical milestones with environmental permits and a 25-year mining concession for its Nunasvaara South graphite mine, alongside securing a €70 million EU Innovation Fund grant for its Luleå Anode Refinery, positioning it at the forefront of Europe's battery materials supply chain.

Southern Palladium has upgraded its Bengwenyama PGM project resource to 40.25 million ounces and delivered a positive prefeasibility study with a post-tax NPV of USD 1.059 billion, marking a pivotal step from exploration to development.

Australis Oil & Gas reported a 3% rise in sales volume for Q4 2024 despite a slight dip in revenue due to lower commodity prices, while actively pursuing partnerships to unlock the full potential of its Tuscaloosa Marine Shale assets.

Renascor Resources advances its Battery Anode Material project with the Early Contractor Involvement phase nearing completion, alongside securing major project status and progressing its Purified Spherical Graphite demonstration plant.

Gold Hydrogen Ltd has reported the detection of rare Helium-3 in its Ramsay Project gas samples, alongside record-high helium purities, while expanding its exploration footprint in South Australia.

FinTech Chain Limited reports a robust increase in cash balances and positive operating cash flow for Q3 2024, alongside new contract wins and ongoing legal proceedings related to a past misappropriation case.

Cann Group Limited reported a positive operating cash flow for Q2 2024, driven by an R&D tax credit refund, while ramping up production and navigating pricing pressures in the medicinal cannabis market.

Felix Gold Limited is advancing plans for near-term antimony production at its historic Scrafford Mine in Alaska, backed by a recent $4.8 million capital raise and strategic positioning amid critical mineral shortages in the U.S.

Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.